Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a causative agent of the pandemic coronavirus disease 2019 (COVID-19), which has resulted in over two million deaths worldwide to date. Diphyllin and diphyllinosides are known as natural blockers of cellular vacuolar ATPases, and so can...
Main Authors: | Michal Stefanik, Petra Strakova, Jan Haviernik, Andrew D. Miller, Daniel Ruzek, Ludek Eyer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/3/471 |
Similar Items
-
Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses
by: Michal Štefánik, et al.
Published: (2022-02-01) -
Bioactivities and Mechanisms of Action of Diphyllin and Its Derivatives: A Comprehensive Systematic Review
by: Wen Hou, et al.
Published: (2023-11-01) -
Cloning, Expression and Purification of Subunit H of Vacuolar H+-ATPase from Mythimna separata Walker (Lepidoptera: Noctuidae)
by: Lina Lu, et al.
Published: (2014-09-01) -
Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity
by: Sushma Bartaula-Brevik, et al.
Published: (2023-08-01) -
In vivo anti‐V‐ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses
by: Arpita Kulshrestha, et al.
Published: (2020-10-01)